ISCaM 2024
Registration
  • Home
  • Committees
  • Program
    • Mobile app
    • Scientific program
    • Instructions to authors
    • Profile page
  • Speakers
  • Sponsorship
  • Information
    • Fees & deadlines
    • Travel Grant
    • Destination
    • Venue
    • Accommodation
    • Gala Dinner
    • Cancellation policy
  • Contacts
  • Home
  • Committees
  • Program
    • Mobile app
    • Scientific program
    • Instructions to authors
    • Profile page
  • Speakers
  • Sponsorship
  • Information
    • Fees & deadlines
    • Travel Grant
    • Destination
    • Venue
    • Accommodation
    • Gala Dinner
    • Cancellation policy
  • Contacts

About

Cancers are characterized by a high metabolic heterogeneity allowing cancer cells to survive and proliferate in harsh microenvironmental conditions, including hypoxia, acidosis and limited availability to metabolic resources. In the recent years, a growing body of experimental and clinical evidence has been obtained suggesting that the metabolic plasticity of malignant cells plays a key role in cancer progression. Indeed, metabolic activities of cancer cells directly influence (epi)genetic modifications, intra- and inter-cellular signaling, metastatic process, immune escape and response of tumors to different anticancer therapies. Recent technical developments have allowed to reveal the spatially- and temporally-resolved complexity of the metabolic networks within tumors and its role in tumor initiation and progression.

The ISCaM2024 symposium is intended to be multidisciplinary with, as a principal aim, the dissemination of the most recent knowledge related to tumor metabolism, with a special focus on the interactions between cancer cells and their microenvironment and on the alterations of the various hallmarks of cancer.

Main topics

  • Immunometabolism
  • Lipid metabolism and ferroptosis
  • Metabolism and therapy resistance
  • Tumor microenvironment and disease progression
  • Epigenetics, circadian clock and cancer metabolism
  • Tumor acidosis and imaging

Invited speakers

  • Matthew Vander Heiden – Koch Institute at MIT, Cambridge, MA, USA
  • Costas Lyssiotis – University of Michigan – Ann Arbor, MI, U.S.A.
  • Fatima Mechta-Grigoriou – Institut Curie – Paris, France
  • Gina DeNicola – Moffitt Cancer Center – Tampa, FL, U.S.A.
  • Issam Ben-Sahra – Feinberg School of Medicine – Chicago, IL, U.S.A.
  • Jean-Emmanuel Sarry – CRCT-Oncopole – Toulouse, France
  • Johannes Meiser – Luxembourg Institute of Health
  • Ping-Chih Ho – Ludwig Institute for Cancer Research – Lausanne, Switzerland
  • Rushika Perera – UCSF – San Francisco, CA, U.S.A.
  • Sara Sdelci – CRG – Barcelona, Spain
  • Sarah-Maria Fendt – VIB KU Leuven Center for Cancer Biology – Leuven, Belgium
  • Sirio Dupont – University of Padua – Padua, Italy
  • Vignir Helgason – University of Glasgow – Glasgow, UK
  • Andrea Morandi – University of Florence – Italy
  • Mathias Wenes – Center for Translational Research in Onco-Hematology, University of Geneva – Switzerland
Read more

Join the 2024 conference in Brussels!

Submit an abstract and register for the event

Registration

Thank you for your support!

Contact

For any request, please contact:

   +33 (0)2 47 27 33 30
   secretary@iscam2024.org

Icones from www.icones8.fr
Important dates

NEW! Submission deadline: April 30th, 2024
Early registration deadline: May 15th, 2024
Travel Grant application deadline: May 15th, 2024
Gala dinner: July 4th, 2024

Supports & Sponsors
EMBO_logo
Logo_FNRS
Logo_UC Louvain
avantor_logo_rgb
Logo Bio-Connect
University_of_Liège_logo.svg
2017_PromegaLogo_Sol
cells-logo
metabolites-logo-print
cancers-logo-print
organoids-logo
2560px-Agilent_Technologies-Logo
Logo Frontiers
Don Whitley Scientific
2560px-Agilent_Technologies-Logo
Powered by VERT COM agency | Privacy policy